HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bayer Keeping One-A-Day Cold Season Name Despite FDA Reservations

This article was originally published in The Tan Sheet

Executive Summary

Bayer does not plan to change the Cold Season name for its One-A-Day supplement despite FDA recommendations. The agency sent Bayer a "courtesy" letter in September advising the product name "suggests [the supplement] is intended to prevent, treat or mitigate disease, namely the common cold" (The Tan Sheet" Nov. 23, 1998, p. 10).

You may also be interested in...



Fewer Structure/Function Claims Deemed Inappropriate By FDA In 1999

Cold, allergy and immune system claims were the most commonly cited statements in FDA "courtesy" letters issued to dietary supplement companies in 1999, although the number of letters addressing these conditions declined from 1998.

Source Naturals Chem-Defense For MCS Subject To FDA "Courtesy" Letter

Source Naturals was sent a June 18 FDA "courtesy" letter for making drug claims for Chem-Defense, a sublingual dietary supplement. The advisory letter states two claims - "For persons with chemical sensitivities" and "For chemically sensitive individuals" - suggest the product "is intended to treat, cure, prevent or mitigate disease," and is therefore a drug. Dietary supplements for multiple chemical sensitivities, or MCS, are relatively rare.

Bayer One-A-Day

Two new products in the specialized supplement line, Bedtime & Rest and Joint Health, will begin shipping July 6 with distribution expected to be completed by August. The 30-count products are the first new introductions to the One-A-Day herbals line. Bedtime & Rest is formulated with kava kava, valerian, magnesium and calcium and Joint Health contains glucosamine, devil's claw, vitamins C and E and manganese. Labeling suggests taking three capsules a day of Joint Health and two capsules of Bedtime & Rest one hour before sleeping. Pricing will be comparable to the rest of the line, which retails for between $8.99 and $9.99. An FSI featuring Bedtime & Rest and Joint Health is scheduled to drop in September along with a TV spot for Joint Health

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS140644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel